Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 31 - 60 of 253
Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Rebif - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Reblozyl - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Recarbrio - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Recikalc-D 500 mg-400 IU tabletti, kalvopäällysteinen SPC 2024-11-13 Uusi

PL

Itsehoito

Recipect oraaliliuos SPC 2022-06-09

PL

Itsehoito

Recreol 50 mg-g emulsiovoide SPC 2024-01-17

PL

Itsehoito

Recreol 50 mg-g voide SPC 2024-01-17

PL

Resepti

Rectogesic 4 mg-g rektaalivoide SPC 2024-03-15

European Medicines Agency's website:
ReFacto AF - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Refixia - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Regiocit hemofiltraationeste SPC 2024-08-01 Uusi

European Medicines Agency's website:
Regkirona - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Rehydron Optim jauhe oraaliliuosta varten SPC 2023-06-15

European Medicines Agency's website:
Rekambys - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Rekovelle - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Relafalk 200 mg säädellysti vapauttava tabletti SPC 2024-01-29

PL

Resepti

Relenza 5 mg-annos inhalaatiojauhe, annosteltu SPC 2023-12-19

PL

Resepti

Relert 40 mg tabletti, kalvopäällysteinen SPC 2023-11-01

PL

Resepti

Relfydess 100 yksikköä-ml injektioneste, liuos SPC 2024-10-07

PL

Resepti

Relifex 500mg ja 1g tabletti, 1g liukeneva tabletti SPC 2020-10-02

European Medicines Agency's website:
Relistor - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Relvar Ellipta - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Remicade - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Remifentanil B. Braun 1 mg, 2 mg, 5 mg kuiva-aine välikonsentraatiksi injektio-infuusionestettä varten, liuos SPC 2022-05-12

PL

Resepti

Remifentanil hameln 1 mg, 2 mg, 5 mg kuiva-aine välikonsentraatiksi injektiö/infuusionestettä varten, liuos SPC 2022-04-21

PL

Resepti

Remifentanil Orion 1 mg, 2 mg, 5 mg kuiva-aine välikonsentraatiksi injektio-infuusionestettä varten, liuos SPC 2023-07-25

PL

Resepti

Reminyl 8 mg + 16 mg depotkapseli, kova SPC 2021-11-15

PL

Resepti

Reminyl 8 mg, 16 mg, 24 mg depotkapseli, kova SPC 2021-11-15

PL

Resepti

Remodulin 1 mg-ml infuusioneste, liuos SPC 2022-03-21

PL

Resepti

Remodulin 10 mg-ml infuusioneste, liuos SPC 2022-03-21

Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >